SunRISe-1 bladder cancer trial posts Phase 2b results; TiTan myeloma trial registeredJul 31Weekly roundup, 2 itemsdaratumumabJohnson & Johnson
Montefiore registers Phase 1 trial pairing Talquetamab with belantamab mafodotin in myelomaJul 22Trial updatebelantamabbelantamab mafodotin
J&J raises 2026 sales and EPS guidance after strong Q2 resultsJul 15Quarterly updateJohnson & Johnson
Sign inSign in